E. Bessa
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Head and Neck Cancer Studies 7
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Nadia Amellal (7 shared papers)Ricardo Hitt (5 shared papers)Jean Bourhis (4 shared papers)E Vilmer (2 shared papers)Évelyne Jacqz-Aigrain (2 shared papers)Xavier León (1 shared paper)Adorján F. Kovács (1 shared paper)Andrea Rocca (1 shared paper)
In The Last Decade
E. Bessa
11 papers receiving 370 citations
Peers
Comparison fields: 5 of 49
- Otorhinolaryngology 145
- Oncology 170
- Pulmonary and Respiratory Medicine 112
- Public Health, Environmental and Occupational Health 49
- Transplantation 4
Countries citing papers authored by E. Bessa
This map shows the geographic impact of E. Bessa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bessa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bessa more than expected).
Fields of papers citing papers by E. Bessa
This network shows the impact of papers produced by E. Bessa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bessa. The network helps show where E. Bessa may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Bessa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 139 | |
| 2 | 2004 | 87 | |
| 3 | 1994 | 54 | |
| 4 | 2004 | 26 | |
| 5 | 1997 | 24 | |
| 6 | 2004 | 20 | |
| 7 | [Phase II study of docetaxel in inoperable advanced non small cell lung cancer]. | 2000 | 9 |
| 8 | [Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology]. | 2000 | 8 |
| 9 | 2003 | 3 | |
| 10 | 2003 | 3 | |
| 11 | 2004 | 3 |
About E. Bessa
E. Bessa is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 376 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers), Acute Lymphoblastic Leukemia research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Childhood Cancer Survivors' Quality of Life (1 paper) and Prenatal Screening and Diagnostics (1 paper). The work is most often cited by research in Otorhinolaryngology (145 citations), Oncology (170 citations), Pulmonary and Respiratory Medicine (112 citations), Public Health, Environmental and Occupational Health (49 citations) and Transplantation (4 citations). E. Bessa has collaborated with scholars based in France, Germany and Spain. Frequent co-authors include Nadia Amellal, Ricardo Hitt, Jean Bourhis, E Vilmer, Évelyne Jacqz-Aigrain, Xavier León, Adorján F. Kovács, Andrea Rocca, Roger Stupp and Manuel Constenla. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Clinical Oncology and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.